Aethlon Stock Analysis

AEMD -  USA Stock  

USD 5.22  0.14  2.61%

The latest price surge of Aethlon Medical could raise concerns from shareholders as the firm it trading at a share price of 5.22 on 826,700 in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 49.14. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Aethlon Medical partners.
Please continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Aethlon Medical stock analysis report makes it easy to digest most publicly released information about Aethlon Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Aethlon stock analysis module also helps to analyze the Aethlon Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Aethlon Stock Analysis Notes

The company recorded a loss per share of 0.71. Aethlon Medical had not issued any dividends in recent years. The entity had 1:50 split on the 15th of October 2019. Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. For more info on Aethlon Medical please contact James Joyce at 858 459 7800 or go to http://www.aethlonmedical.com.

Aethlon Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aethlon Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aethlon Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aethlon Medical is way too risky over 90 days horizon
Aethlon Medical appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 831.6 K. Net Loss for the year was (7.41 M) with profit before overhead, payroll, taxes, and interest of 650.19 K.
Aethlon Medical currently holds about 12.13 M in cash with (6.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0.
Aethlon Medical has a frail financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Aethlon Medical Inc falls -4.3180 percent for June 15 - Equities.com

Aethlon Medical Upcoming and Recent Events

Earnings reports are used by Aethlon Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aethlon Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of June 2021
Next Earnings Report10th of August 2021
Next Fiscal Quarter End31st of March 2021
Next Fiscal Year End24th of June 2021
Last Quarter Report31st of December 2020
Last Earning Announcement31st of March 2020

Aethlon Largest EPS Surprises

Earnings surprises can significantly impact Aethlon Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-10-28
2020-09-30-0.12-0.15-0.0325 
2021-02-10
2020-12-31-0.165-0.2-0.03521 
2018-11-06
2018-09-30-1.05-1.2-0.1514 
View All Earnings Estimates

Aethlon Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Aethlon Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Aethlon Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Aethlon Medical specific information freely available to individual and institutional investors to make a timely investment decision.
11th of June 2021
Financial Statements and Exhibits. Other Events
View
22nd of March 2021
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
View
22nd of February 2021
Unclassified Corporate Event
View
10th of February 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
29th of January 2021
Unclassified Corporate Event
View
13th of January 2021
Unclassified Corporate Event
View
11th of January 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
10th of December 2020
Entry into a Material Definitive Agreement
View

Aethlon Medical Thematic Classifications

In addition to having Aethlon Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Measuring and Control IdeaMeasuring and Control
USA Equities from Measuring and Control industry as classified by Fama & French

Aethlon Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aethlon Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aethlon Medical backward and forwards among themselves. Aethlon Medical's institutional investor refers to the entity that pools money to purchase Aethlon Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Renaissance Technologies LlcCommon Shares306.3 K622 K
Vanguard Group IncCommon Shares171.2 K347 K
Geode Capital Management LlcCommon Shares66.8 K135 K
Northern Trust CorpCommon Shares21.5 K44 K
Virtu Financial LlcCommon Shares19.8 K40 K
Cardan Capital Partners LlcCommon Shares15.9 K32 K
First Midwest Bank Trust DivisionCommon Shares15.2 K31 K
Note, although Aethlon Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aethlon Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 78.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aethlon Medical's market, we take the total number of its shares issued and multiply it by Aethlon Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Aethlon Profitablity

Aethlon Medical's profitability indicators refer to fundamental financial ratios that showcase Aethlon Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Aethlon Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aethlon Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aethlon Medical's profitability requires more research than a typical breakdown of Aethlon Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(1.52) (1.64) 
Return on Average Equity(1.57) (1.69) 
Return on Invested Capital 14.39  15.53 
Return on Sales(8.75) (9.44) 

Management Efficiency

The entity has return on total asset (ROA) of (53.38) % which means that it has lost $53.38 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (97.28) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical management efficiency ratios could be used to measure how well aethlon medical manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Invested Capital is expected to grow to 15.53, whereas Return on Average Assets are forecasted to decline to (1.64) . Aethlon Medical Current Assets are projected to increase significantly based on the last few years of reporting. The past year's Current Assets were at 11.55 Million. The current year Assets Non Current is expected to grow to about 430 K, whereas Return on Average Assets are forecasted to decline to (1.64) .
Last ReportedProjected for 2021
Book Value per Share 3.17  3.42 
Enterprise Value over EBIT(2.30) (2.48) 
Enterprise Value over EBITDA(1.84) (1.98) 
Price to Book Value 1.35  1.38 
Tangible Assets Book Value per Share 3.48  4.42 
Enterprise Value9.1 M13.4 M
Tangible Asset Value11.9 M12.8 M

Technical Drivers

As of the 19th of June, Aethlon Medical shows the Downside Deviation of 6.88, risk adjusted performance of 0.0752, and Mean Deviation of 12.75. Aethlon Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for Aethlon Medical, which can be compared to its rivals. Please confirm Aethlon Medical treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Aethlon Medical is priced correctly, providing market reflects its regular price of 5.22 per share. Given that Aethlon Medical has jensen alpha of 5.21, we suggest you to validate Aethlon Medical's prevailing market performance to make sure the company can sustain itself at a future point.

Aethlon Medical Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Triangular Moving Average shows Aethlon Medical double smoothed mean price over a specified number of previous prices (i.e., averaged twice). View also all equity analysis or get more info about triangular moving average overlap studies indicator.

Aethlon Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aethlon Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Guy Cipriani over two months ago via Macroaxis 
Payment of 2575 shares by Guy Cipriani of Aethlon Medical subject to Rule 16b-3
Larosa Steven P over three months ago via Macroaxis 
Acquisition by Larosa Steven P of 120883 shares of Aethlon Medical subject to Rule 16b-3
Guy Cipriani over three months ago via Macroaxis 
Acquisition by Guy Cipriani of 120883 shares of Aethlon Medical subject to Rule 16b-3
Guy Cipriani over three months ago via Macroaxis 
Payment of 2575 shares by Guy Cipriani of Aethlon Medical subject to Rule 16b-3
Chetan Shah over six months ago via Macroaxis 
Sale by Chetan Shah of 334 shares of Aethlon Medical
Guy Cipriani over six months ago via Macroaxis 
Payment of 2389 shares by Guy Cipriani of Aethlon Medical subject to Rule 16b-3
Guy Cipriani over six months ago via Macroaxis 
Acquisition by Guy Cipriani of 929 shares of Aethlon Medical subject to Rule 16b-3
Guy Cipriani over six months ago via Macroaxis 
Payment of 2389 shares by Guy Cipriani of Aethlon Medical subject to Rule 16b-3
Guy Cipriani over a year ago via Macroaxis 
Payment of 3684 shares by Guy Cipriani of Aethlon Medical subject to Rule 16b-3
James Frakes over a year ago via Macroaxis 
Exercise or conversion by James Frakes of 1565 shares of Aethlon Medical subject to Rule 16b-3
Edward Broenniman over a year ago via Macroaxis 
Sale by Edward Broenniman of 12500 shares of Aethlon Medical
Guy Cipriani over a year ago via Macroaxis 
Acquisition by Guy Cipriani of 23893 shares of Aethlon Medical subject to Rule 16b-3

Aethlon Medical Predictive Daily Indicators

Aethlon Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aethlon Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aethlon Medical Forecast Models

Aethlon Medical time-series forecasting models is one of many Aethlon Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aethlon Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Aethlon Medical Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aethlon Medical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aethlon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Aethlon Medical. By using and applying Aethlon Stock analysis, traders can create a robust methodology for identifying Aethlon entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(8.71) (9.40) 
Gross Margin 0.90  0.89 
Profit Margin(8.82) (9.52) 
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 8 people.

Current Aethlon Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aethlon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aethlon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
6.33Strong Buy3Odds
Aethlon Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Aethlon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aethlon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aethlon Medical, talking to its executives and customers, or listening to Aethlon conference calls.
Aethlon Analyst Advice Details

Aethlon Stock Analysis Indicators

Aethlon Medical stock analysis indicators help investors evaluate how Aethlon Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aethlon Medical shares will generate the highest return on investment. By understating and applying Aethlon Medical stock analysis, traders can identify Aethlon Medical position entry and exit signals to maximize returns.
Quick Ratio9.91
Fifty Two Week Low1.22
Revenue Growth51.10%
Shares Short Prior Month461.15k
Average Daily Volume Last 10 Day42.64M
Average Daily Volume In Three Month5.06M
Shares Percent Shares Out2.37%
Gross Margins100.00%
Short Percent Of Float2.49%
Forward Price Earnings-7.05
Float Shares12.03M
Fifty Two Week High12.49
Enterprise Value To Ebitda-1.32
Fifty Day Average2.39
Two Hundred Day Average2.26
Enterprise Value To Revenue11.72
Please continue to Trending Equities. Note that the Aethlon Medical information on this page should be used as a complementary analysis to other Aethlon Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Aethlon Medical Stock analysis

When running Aethlon Medical price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Aethlon Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.